ArticleFrontiers in oncology2025

Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer.

Jiabin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.